Review
Open access
Oct 2026
Chimeric antigen receptor t-cell therapy for systemic autoimmune diseases: a systematic review
Emerging evidence suggests CAR T-cell therapy is associated with rapid, sustained clinical remission in severe, refractory cases, particularly Systemic Lupus Erythematosus, and demonstrates promise as a novel therapeutic strategy for refractory autoimmune diseases.
UF Ofodile, D. Davidson, OH Ezemaduka et al.
· European Journal of Public H... · 0 citations